Trade Mark Journal No.2026/013 27 March 2026
WO0000001906655 (42)
Office of origin: United States of America
Date of International Registration:21 January 2026
Date of designation in the UK:
21 January 2026

International priority date claimed: 20 October 2025
(United States of America)
(99452284)
- Class 42
- Chemical research; biotechnology research; scientific research and development; pharmaceutical research and development; pharmaceutical drug development services.
Athira Pharma, Inc.
Representative: Kevin S. Costanza Seed Intellectual Property Law Group LLP, 701 5th Avenue, Suite 5400, Seattle WA 98104, UNITED STATES OF AMERICA